Development and in vitro evalution of guar gum based fluconazole in situ gel for oral thrush

Journal of Pharmaceutical Sciences and Research

Volumn 4, Issue 12, 2012, Pages 2009-2014

  Jaya Raja Kumar, K ^a   Muralidharan, Selvadurai ^a   Dhanaraj, Sokkalingam Arumugam ^a  

^a AIMST UNIVERSITY   (Malaysia)

Author keywords

Carbomer 934; Fluconazole; Guar gum; HPMC; In situ gel; Oral thrush

Indexed keywords

ALGINIC ACID; CALCIUM CHLORIDE; CARBOPOL 934; CITRATE SODIUM; DIMETHYL SULFOXIDE; FLUCONAZOLE; GUAR GUM; PROPYL PARABEN; TRIETHANOLAMINE;

ANIMAL TISSUE; ARTICLE; CHICKEN; CONTENT UNIFORMITY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG FORMULATION; DRUG INCOMPATIBILITY; DRUG RELEASE; DRUG SCREENING; GEL; GEL STRENGTH; GELLING CAPACITY; IN SITU GEL; INFRARED SPECTROSCOPY; MUCOADHESION; NONHUMAN; PH; PHYSICAL PARAMETERS; THRUSH; VISCOSITY;

EID: 84871501840     PISSN: 09751459     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Axell T, Samaranayake LP, Reichart PA, and Olsen I, A proposal for reclassification of oral candidosis. Oral Surg. Oral Med. Oral Pathol. 1997; 84: 111-112.
2. Knight L and Fletcher J. Growth of Candida albicans in saliva: stimulation by glucose associated with antibiotics, corticorsteroids and diabetes mellitus. J. Infect. Dis. 1971; 123:371-377.
3. Seelig MS, Mechanisms by which antibiotics increase the incidence and severity of candidiasis and alter the immunological defenses. Bacteriol. Rev. 1966; 30: 442-459.
4. Saltarelli CG, Gentile KA, and Mancuso SC, Lethality of Candida strains as influenced by the host. Can. J. Microbiol. 1975; 21:648-654.
5. Taschdjian CL, Seelig MS, and Kozinn PJ, Serological diagnosis of candidiasis. Crit. Rev. Clin. Lab. Sci. 1973; 4:19-60.
6. Heimdahl A, and Nord CE, Oral yeast infections in immune compromised and seriously diseased patients. Acta Odontol. Scand. 1990; 48:77-84.
7. Horn R, Wong B, and Kiehn TE, Fungemia in a cancer hospital: changing frequency, earlier onset, and results of therapy. Rev. Infect. Dis. 1985; 7:646-655.
8. Wingard JR, Merz WG, Rinaldi MG, Johnson TR, Karp JE, and Saral R, Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole. N. Engl. J. Med. 1991; 325:1274-1277.
9. Bodey GP, Fungal infection and fever of unknown origin in neutropenic patients. Am. J. Med. 1986; 80:112-119.
10. Gold JWM, Opportunistic fungal infections in patients with neoplastic disease. Am. J. Med. 1984; 76:458-463.
11. Maksymuik AW, Thongprosert S, and Hopfer R, Systemic candidiasis in cancer patients. Am. J. Med. 1984; 77:20-27.
12. Kauffman CA and Carver PL, Antifungal agents in the 1990s. Current status and future developments. Drugs 1997; 53:539-549.
13. Kauffman CA. Role of azoles in antifungal therapy. Clin. Infect. Dis. 1996; 22:148-153.
14. Tortorano AM, Viviani MA, Brachiesi F, Arzani D, Rigoni AL, Cogliati M, et al, Comparison of three methods for testing azole susceptibilities of C. albicans strains isolated sequentially from oral cavities of AIDS patients. J. C.in. Microbiol. 1988; 36, 1578-1583
15. Samaranayake YH and Samarnayake LP. Candida krusei: biology, epidemiology, pathogenicity and clinical manifestations of an emerging pathogen. J. Med. Microbiol. 1994; 41:295-310.
16. Kornman KS, Controlled release local delivery of antimicrobials in periodentics: Prospects of the future. J.Periodental 1993; 64: 782-791.
17. Mumtaz AM and Chng HS. Design of a dissolution apparatus suitable for in situ release study of triamcinolone acetonide from bioadhesive buccal tablets. Int. J. Pharm. 1995; 121: 129-139.
18. Mohammadi-Samani S, Bahri-Najafi R and Yousefi G. Formulation and in vitro evaluation of prednisolone buccoadhesive tablets. Fármaco (Prat)., 2005; 60: (4), 339-344
19. Mitan R, Gokulgandhi Jolly R, Parikh, Megha B and Dharmesh MM. A pH triggered in situ gel forming ophthalmic drug delivery system fortropicamide. Drug Deliv Technol 2007; 5: 44-49.
20. Pandit D, Bharathi, A, Srinatha, Ridhurkar, Singh S., Long acting ophtha lmic formulation of indomethacin: Evaluation of alginate gel systems. Indian J Pharm Sci 2007; 69: 37-40.
21. Choi HG, Jung JH, Ryu JM, Yoon SJ, Oh YK, Kim CK, Development of in situ-gelling and mucoadhesive acetaminophen liquid suppository. Int J Pharm.1998; 165:33-44.
22. Koffi FAA, Agnely G, Ponchel JL, Grossiord,Modulation of the rheological and mucoadhesive properties of thermosensitive pluronicbased hydrogels intended for the rectal administration of quinine. European Journal of Pharmaceutical Sciences.2006; 27:328-335.
23. Harish Matapady,Narayana. Development of a gellan gum based mucoadhesive in situ gels for buccal local delivery system of fluconazole, int.j.chhem.sci: 2009; 7: 315-326.
24. Jagdish Balasubramaniam, In vitro and in vivo evaluation of the Gelrite gellan gum-based ocular delivery system for indomethacin, Acta Pharm. 2003; 53: 251-261.